100% activity
Freshly isolated cells preserve full therapeutic potential. After thawing, frozen cells lose 30-40% of viability.
STEM CELL CHINA / SHANGRAO
Advanced cellular therapy under the scientific leadership of academician Han Zhongchao. Treatment of neurodegenerative, cardiovascular, endocrine and autoimmune disorders with freshly isolated stem cells.
By the numbers / 02
Why living / 03
Frozen cells lose 30-40% of their activity upon thawing. Freshly isolated cells retain 100%. This is the scientific cornerstone of our protocol.
Freshly isolated cells preserve full therapeutic potential. After thawing, frozen cells lose 30-40% of viability.
Cells are prepared individually for each patient over 6 days. No years-long storage in liquid nitrogen.
A known population profile and activity — your physician calculates dosage based on body weight and diagnosis.
No cryoprotectants and no freeze-thaw cycle — reducing the immunological burden on the patient.
Process / 04
From the first consultation to post-treatment follow-up — we are with you at every stage.
We review your medical records and case history. Our academic board evaluates whether cell therapy is the right path for you.
We design a personal protocol: cell type, administration route, dosage and number of procedures tailored to your diagnosis.
We assist with medical visa, flights and accommodation. Free transfer from Sanqingshan Airport.
A course of 3 procedures spaced 15–20 days apart. Therapy and rehabilitation at Hanshi United under medical supervision.
Remote consultations after you return home. The effect unfolds over 3–6 months — we stay with you throughout.
Treatments / 05
From neurodegenerative diseases to endocrine disorders. About 30 nosologies, with an individual protocol for each diagnosis.
Cerebral palsy, autism, stroke, Parkinson's, ALS, spinal cord injuries, Alzheimer's, TBI, epilepsy, MS, dementia — living-cell neuroregenerative therapy.
SLE, rheumatoid arthritis, psoriasis, scleroderma — immunomodulation with mesenchymal cells.
MI, heart failure, ischemic cardiomyopathy, dilated cardiomyopathy, atherosclerosis — myocardial regeneration.
Type 1 and type 2 diabetes, diabetic complications, hormonal disorders.
Premature ovarian failure, uterine adhesions, reproductive health.
Osteoarthritis, avascular necrosis, osteoporosis, delayed fracture healing, tendon and ligament injuries.
Liver fibrosis and cirrhosis, liver failure, Crohn's disease, ulcerative colitis.
Hematopoietic recovery, prevention of graft-versus-host disease (GVHD).
Founder / 06
Member of the French Academy of Medicine and the French Academy of Technologies. H-index 81.
韩忠朝
Member of the French National Academy of Medicine and the French Academy of Technologies, founder of Han's United
Discovered differentiation of hematopoietic stem cells into vascular cells. Developed 8 first-class therapeutics. H-index 81, over 600 publications, 380+ in SCI journals. Listed in Stanford's top-2% scientists worldwide (2022).
Cases / 07
Real clinical cases from the practice of Hanshi United. Names and ages are published with the consent of the families.
Case · 01 / NY
6 · China
Regression starting at 1.5 years: loss of language, cognitive skills, and eye contact
Recovery of eye contact, return to communication, progress in cognitive function.
Case · 02 / FL
6 · 21 кг · China
Unintelligible speech, EEG abnormalities
EEG normalised after the course. Marked speech improvement.
Case · 03 / LC
2 · 13 кг · China
Limited speech, weak eye contact, hydrocephalus, nocturnal seizures
Reduced seizure frequency, improved motor skills, progress in speech development.
Case · 04 / SW
2 · 14 кг · China
Functional delays from age 1, unsteady sitting, leukoencephalopathy, epilepsy
Epileptic activity stabilised. Improved postural control.
Trust / 08
Eight academicians and professors from France and beyond serve on our scientific advisory board.
Jacques CAEN
French Academy of Medicine, Academy of Technologies, Corresponding Member of the Academy of Sciences
Bruno JARRY
President of the National Academy of Medicine of France
Jean-Pierre CAZENAVE
Member of the French Academy of Medicine
Jean-Francois STOLTZ
Professor of medicine at the University of Lorraine
Georges UZAN
Member of the French Academy of Medicine, director of INSERM U972
Jean-Jacques LATAILLADE
Professor, director of the cell therapy centre at Percy Military Hospital (France)
Raymond ASTRI
Senior engineer, big-data architecture
Constantin AGOURIDAS
Professor at ENSCP, chief expert at IMCELL Lab
CMA
Accreditation by the China Metrology Administration for laboratory measurements and analysis.
CNAS
Accreditation by the China National Accreditation Service for Conformity Assessment — internationally recognised laboratory quality mark.
ISO 9001
International quality management system standard for healthcare service organisations.
Get started / 10
Tell us about the patient — our academic board will review the case and propose a treatment protocol.
Medical questionnaire · 10–15 min
If you are ready to share the medical history and documents in advance, please fill out the detailed questionnaire. This helps the academic board prepare a personal protocol before the first conversation.
We use cookies and analytics services to improve the website experience. Privacy Policy